Revenue is up more than expected at Auckland-based, ASX-listed soft tissue regeneration biotech Aroa Biosurgery, according to unaudited, preliminary figures released on Tuesday.
Chief executive and founder Brian Ward said the company was on track to hit $100 million annual sales revenues in the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
